Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Debt/Equity

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Total Debt/Equity(x) 0.250.130.460.400.67

What is the latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS is 0.25 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.25
Mar20240.13
Mar20230.46
Mar20220.40
Mar20210.67

How is Total Debt/Equity of GLENMARK PHARMACEUTICALS Trending?

Years Total Debt/Equity % Change
Mar2025 0.25
92.31
Mar2024 0.13
-71.74
Mar2023 0.46
15.00
Mar2022 0.4
-40.30
Mar2021 0.67 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Total Debt/Equity ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,818.9 Cr 1.6% 3% 47.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr -0.5% 3.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.5% 10% 41.5% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹108,703.0 Cr -1.7% 1% -10.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.6%

3%

47.9%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses